Hemangioblastoma diagnosis and surveillance in von Hippel-Lindau disease: a consensus statement.

Huntoon, Kristin; Shepard, Matthew J; Lukas, Rimas V; McCutcheon, Ian E; Daniels, Anthony B; Asthagiri, Ashok R

Huntoon, Kristin; Shepard, Matthew J; Lukas, Rimas V; McCutcheon, Ian E; Daniels, Anthony B; Asthagiri, Ashok R.

Afiliação

Huntoon K; 1Department of Neurological Surgery, The Ohio State University Wexner Medical Center, Ohio State University, Columbus, Ohio.
Shepard MJ; 4Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, Texas; and.
Lukas RV; 2Department of Neurological Surgery, University of Virginia Health System, Charlottesville, Virginia.
McCutcheon IE; 4Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, Texas; and.
Daniels AB; 3Department of Neurology, Lou and Jean Malnati Brain Tumor Institute, Northwestern University, Chicago, Illinois.
Asthagiri AR; 4Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, Texas; and.

J Neurosurg ; 136(6): 1511-1516, 2022 Jun 01.

Article em En | MEDLINE | ID: mdl-34598132

Palavras-chave

hemangioblastoma; magnetic resonance imaging; oncology; surveillance; von HippelLindau disease

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Guideline / Prognostic_studies / Screening_studies / Systematic_reviews Idioma: En Revista: J Neurosurg Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google